A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.

For decades, all-in-one washer-dryer combos had a bad reputation for tiny drums and marathon cycle times. Thankfully, times ...

MSD and Eisai presented the data at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The ...

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, ...

The potential of moving the combination to the earlier MIBC setting significantly increases the Padcev market.

BERLIN -- The investigational tyrosine kinase inhibitor (TKI) zanzalintinib plus atezolizumab (Tecentriq) significantly ...

For years, MASH was where drug development dreams went to die.  | After Rezdiffra’s approval and Wegovy’s label expansion, ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

In patients with obstructive sleep apnea, combining supplemental oxygen with a mandibular advancement device leads to greater ...

Camrelizumab/famitinib combination significantly improved PFS and OS over platinum-based chemotherapy in recurrent/metastatic ...

The combo of Daisy Glow's floral and fruity mix complemented by Major Glow's rich and decadent sandalwoods with a citrus ...

Men with prostate cancer that returns after surgery or radiation and are left with few options could benefit from a new ...